4-Amino-1-N-Fmoc-piperidine hydrochloride, 97.0%, 1g

tert-Butyl (4-oxocycloheptyl)carbamate, 97%, 1g

2,3,4,6,7,11b-Hexahydro-1H-pyrazino[2,1-a]isoquinoline dihydrochloride, 95.0%, 250mg

tert-Butyl (6-bromobenzo[d]thiazol-2-yl)carbamate, 97%, 5g

Nonadecylbenzene>98.0%(GC)5g

4-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-4-CARBONITRILE, 95.0%, 5g

tert-butyl N-[(4-aminotetrahydrothiopyran-4-yl)methyl]carbamate, 97, 250mg

4'-((1r,1'r,4R,4'R)-4'-Ethyl-[1,1'-bi(cyclohexan)]-4-yl)-3,4,5-trifluoro-1,1'-biphenyl, 97%, 10g

3-Oxetanecarboxylic acid, 90.0%, 100mg

2,3-Dimethyl-2H-indazol-6-amine hydrochloride, 95.0%, 25g

N-((4-(5-Methyl-3-phenyl-2,3-dihydrooxazol-4-yl)phenyl)sulfonyl)propionamide, 95.0%, 25mg

Methyl 2-cyano-1H-imidazole-5-carboxylate, 98%, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)